Skip to content

Clinical trials

Completed Carcinoma trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Completed Country / region: Hong Kong Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20081
20093
20101
20141
20161
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AVEO Pharmaceuticals, Inc.1
Ariad Pharmaceuticals1
Bayer1
Chinese University of Hong Kong1
Hoffmann-La Roche1
Imunon1
Ligand Pharmaceuticals1
Pfizer1
Queensland Centre for Gynaecological Cancer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma12
Adenocarcinoma5
Neoplasms5
Carcinoma, Hepatocellular4
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms4
Neoplasms by Histologic Type3
Neoplasms by Site3
Neoplasms, Glandular and Epithelial3
Digestive System Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.